250 related articles for article (PubMed ID: 36524837)
1. Immunocyte Derived Exosomes: Insight into the Potential Chemo-immunotherapeutic Nanocarrier Targeting the Tumor Microenvironment.
Basak M; Chaudhary DK; Takahashi RU; Yamamoto Y; Tiwari S; Tahara H; Mittal A
ACS Biomater Sci Eng; 2023 Jan; 9(1):20-39. PubMed ID: 36524837
[TBL] [Abstract][Full Text] [Related]
2. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
[TBL] [Abstract][Full Text] [Related]
3. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
Srivastava A; Rathore S; Munshi A; Ramesh R
AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
[TBL] [Abstract][Full Text] [Related]
5. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
7. Exploring the dynamic interplay between exosomes and the immune tumor microenvironment: implications for breast cancer progression and therapeutic strategies.
Safaei S; Fadaee M; Farzam OR; Yari A; Poursaei E; Aslan C; Samemaleki S; Shanehbandi D; Baradaran B; Kazemi T
Breast Cancer Res; 2024 Mar; 26(1):57. PubMed ID: 38553754
[TBL] [Abstract][Full Text] [Related]
8. Exosomes-mediated crosstalk between glioma and immune cells in the tumor microenvironment.
Guo X; Sui R; Piao H
CNS Neurosci Ther; 2023 Aug; 29(8):2074-2085. PubMed ID: 37170647
[TBL] [Abstract][Full Text] [Related]
9. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
10. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment.
Rasihashemi SZ; Sahrai H; Rezazadeh-Gavgani E; Yazdani Y; Khalaji A; Lotfinejad P
Med Oncol; 2022 Sep; 39(12):183. PubMed ID: 36071295
[TBL] [Abstract][Full Text] [Related]
11. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
12. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
[TBL] [Abstract][Full Text] [Related]
13. Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes.
Xiong J; Chi H; Yang G; Zhao S; Zhang J; Tran LJ; Xia Z; Yang F; Tian G
Front Immunol; 2023; 14():1188760. PubMed ID: 37342327
[TBL] [Abstract][Full Text] [Related]
14. Exosomes: Powerful weapon for cancer nano-immunoengineering.
Pi YN; Xia BR; Jin MZ; Jin WL; Lou G
Biochem Pharmacol; 2021 Apr; 186():114487. PubMed ID: 33647264
[TBL] [Abstract][Full Text] [Related]
15. m
Zheng J; Feng P; Chen D; Zhang C; Ji Y; Liu Y; Fan X; Li J
Oxid Med Cell Longev; 2022; 2022():9451480. PubMed ID: 36046691
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
[TBL] [Abstract][Full Text] [Related]
17. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
18. Exosome mediated communication within the tumor microenvironment.
Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNAs in tumor microenvironment.
Tan S; Xia L; Yi P; Han Y; Tang L; Pan Q; Tian Y; Rao S; Oyang L; Liang J; Lin J; Su M; Shi Y; Cao D; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2020 Apr; 39(1):67. PubMed ID: 32299469
[TBL] [Abstract][Full Text] [Related]
20. The involvement and application potential of exosomes in breast cancer immunotherapy.
Wang Y; Ma Q; Wang T; Xing J; Li Q; Wang D; Wang G
Front Immunol; 2024; 15():1384946. PubMed ID: 38835784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
